Hantz Financial Services’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3
| Closed | – | – | 1710 |
|
|
2024
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1102 |
|
|
2024
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1080 |
|
|
2024
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1077 |
|
|
2024
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1201 |
|
|
2023
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1131 |
|
|
2023
Q3 | $0 | Sell |
3
-1
| -25% | – | ﹤0.01% | 1119 |
|
|
2023
Q2 | $0 | Buy |
4
+1
| +33% | – | ﹤0.01% | 1087 |
|
|
2023
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 1040 |
|
|
2022
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 1005 |
|
|
2022
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 1004 |
|
|
2022
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 980 |
|
|
2022
Q1 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 981 |
|